Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | TOP1 | P11387 | 2/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 2/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25713098 | 1.00 | TRPV1 (0.32) | TRPV1KDM4ETOP1MAPK14GAA | |
| SCHEMBL25713107 | 0.95 | MAPK14 (0.33) | TRPV1KDM4ETOP1MAPK14L3MBTL1 | |
| SCHEMBL25713032 | 0.95 | MAPK14 (0.33) | TRPV1KDM4ETOP1MAPK14L3MBTL1 | |
| SCHEMBL25713123 | 0.94 | MAPK14 (0.34) | TRPV1KDM4ETOP1MAPK14L3MBTL1 | |
| SCHEMBL25713050 | 0.94 | MAPK14 (0.34) | TRPV1KDM4ETOP1MAPK14L3MBTL1 | |
| SCHEMBL25713154 | 0.93 | KDM4E (0.34) | TRPV1KDM4ETOP1MAPK14 | |
| SCHEMBL25713188 | 0.90 | KDM4E (0.34) | TRPV1KDM4ETOP1MEN1MAPT | |
| SCHEMBL25713202 | 0.90 | CYP17A1 (0.38) | KDM4EMEN1MAPTKMT2A | |
| SCHEMBL25713401 | 0.90 | CYP1A1 (0.31) | TRPV1KDM4E | |
| SCHEMBL25713176 | 0.89 | TOP1 (0.34) | TRPV1KDM4ETOP1MAPK14GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230157159-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2023-05-18 | — | — | US | disclosed |
| US-20230157159-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230157159-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | NR0B1, AHR, ARL1 | TRPV1 612/4885KDM4E 2899/4885TOP1 1473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.